Hubei Biocause Pharmaceutical Co.,Ltd Stock Forecast
Green day on Thursday for Hubei Biocause Pharmaceutical Co.,Ltd
(Updated on Apr 18, 2024)
The Hubei Biocause Pharmaceutical Co.,Ltd stock price gained 1.75% on the last trading day (Thursday, 18th Apr 2024), rising from ¥2.29 to ¥2.33. During the last trading day the stock fluctuated 6.19% from a day low at ¥2.26 to a day high of ¥2.40. The price has fallen in 5 of the last 10 days and is down by -8.27% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 million more shares were traded than the day before. In total, 36 million shares were bought and sold for approximately ¥83.63 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.81% during the next 3 months and, with a 90% probability hold a price between ¥1.81 and ¥2.33 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
000627.SZ Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 4.95%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Hubei Biocause Pharmaceutical Co.,Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at ¥2.34 and ¥2.53. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
A buy signal from a double bottom formation was found on Tuesday, April 16, 2024 and based on theory for this formation the price should go up by 25.46% to ¥2.92 within 45 trading days since signal was issued (Friday, April 19, 2024).
Support, Risk & Stop-loss for Hubei Biocause Pharmaceutical Co.,Ltd stock
Hubei Biocause Pharmaceutical Co.,Ltd finds support from accumulated volume at ¥2.29 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ¥0.140 between high and low, or 6.19%. For the last week, the stock has had daily average volatility of 7.15%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (000627.SZ) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Hubei Biocause Pharmaceutical Co.,Ltd to open at ¥2.33, and during the day (based on 14 day Average True Range), to move between ¥2.21 and ¥2.45, which gives a possible trading interval of +/-¥0.117 (+/-5.02%) up or down from last closing price. If Hubei Biocause Pharmaceutical Co.,Ltd takes out the full calculated possible swing range there will be an estimated 10.05% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at ¥2.29 (1.72%) than the resistance at ¥2.59 (11.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Hubei Biocause Pharmaceutical Co.,Ltd stock A Buy?
Hubei Biocause Pharmaceutical Co.,Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.709 Sell Candidate Unchanged
Predicted Opening Price for Hubei Biocause Pharmaceutical Co.,Ltd of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| ¥2.33 ( 0%) | ¥2.33 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for 000627.SZ
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.47 | 6.01 % | |
| R2 | 2.42 | 3.71 % | ||
| R1 | 2.38 | 2.30 % | ||
| Current price: | 2.33 | |||
| Support | S1 | 2.28 | -2.30 % | |
| S2 | 2.24 | -3.71 % | ||
| S3 | 2.19 | -6.01 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.71 | 16.31 % | |
| R2 | 2.60 | 11.59 % | ||
| R1 | 2.59 | 11.16 % | ||
| Current price | 2.33 | |||
| Support | S1 | 2.29 | -1.72% | |
| S2 | 2.23 | -4.29% | ||
| S3 | 2.22 | -4.72% |
000627 Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | May 30, 2023 | May 30, 2023 | May 30, 2023 | ¥0.110 | 3.46% |
| 2 | Jun 02, 2022 | Jun 02, 2022 | Jun 02, 2022 | ¥0.0050 | 0.170% |
| 3 | Jun 04, 2021 | Jun 04, 2021 | Jun 04, 2021 | ¥0.0100 | 0.258% |
| 4 | May 20, 2020 | May 20, 2020 | May 20, 2020 | ¥0.100 | 1.86% |
| 5 | Sep 26, 2019 | Sep 26, 2019 | Sep 26, 2019 | ¥0.0300 | 0.431% |
FAQ
Click here for our free guide on how to buy Hubei Biocause Pharmaceutical Co.,Ltd Stock.
